Answers are grounded in this paper and cite their sources.
Using a nonconventional pharmacokinetic approach, we showed that gadoterate meglumine undergoes a much faster residual excretion from the body than the linear GBCAs, a process that seems related to the thermodynamic stability of the different chelates. Gadolinium dissociation occurs in vivo for some linear chelates, a mechanism that may explain their long-term retention and slow release from bone. Potential consequences in terms of bone toxicity warrant further investigations.
No takes yet. Share an insight, caveat, or question.
Eric Lancelot (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: